News Category
Lantern Pharma reported Q2 2026 results highlighting progress in its AI-driven oncology pipeline and the establishment of Open Medicine AI as a separa...
Lantern Pharma's upcoming webcast will detail its financial results and clinical milestones, underscoring the company's strategic pivot toward AI-inte...
The U.S. Patent and Trademark Office has allowed a patent for Lantern Pharma's LP-184 therapy selection method using a three-gene biomarker signature,...
Formycon AG and OneSource Specialty Pharma announced a strategic partnership to leverage OneSource's biologics manufacturing capabilities for Formycon...
Lantern Pharma's launch of the ZetaOmics computational biology platform, featuring an autonomous 'Computational Biologist' agent, aims to automate and...
Academy Hunt has expanded its platform to include over 1,000 course comparisons for AI, machine learning, and data science programs in India, helping ...
Quantum Genesis AI Corp. issues a clarification distinguishing its research from Quantumzyme LLP and reaffirming its ownership of key intellectual pro...
Lantern Pharma raised $4.4 million in a registered direct offering, providing capital to advance its AI-powered precision oncology pipeline and potent...
Lantern Pharma announced the expansion of its predictBBB platform into a Large Quantitative Model (LQM), enabling real-time molecular intelligence for...
Lantern Pharma will demonstrate its withZeta.ai AI co-scientist platform in a live public event, showcasing its potential to accelerate oncology drug ...
